← FDA Drug Approvals (Drugs@FDA)
ZITUVIMET
NDA · New Drug Application · Sponsor: ZYDUS LIFESCIENCES · Approved 2023-11-03
Drug application
- FDA Application #
NDA216743- Application type
- New Drug Application
- Brand name
- ZITUVIMET
- Generic name
- SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Active ingredients
- METFORMIN HYDROCHLORIDE; SITAGLIPTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ZYDUS LIFESCIENCES
- Manufacturer
- Zydus Lifesciences Limited
- First approval
- 2023-11-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown